Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation
暂无分享,去创建一个
Rochelle Fu | Amy Cantor | Heidi D Nelson | Linda Humphrey | Miranda Pappas | Monica Daeges | H. Nelson | L. Humphrey | A. Cantor | M. Pappas | M. Daeges | Rochelle Fu
[1] J. Castilla,et al. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme , 2007, Journal of medical screening.
[2] R. Blanks,et al. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality , 2000, BMJ : British Medical Journal.
[3] T. To,et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial , 2014, BMJ : British Medical Journal.
[4] Håkan Jonsson,et al. The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Observational Studies , 2012, Journal of medical screening.
[5] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[6] Philippe Autier,et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database , 2011, BMJ : British Medical Journal.
[7] L. Rutqvist,et al. Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial , 1997, Breast Cancer Research and Treatment.
[8] W. Hepburn,et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening , 1999, The Lancet.
[9] S. Zackrisson,et al. Overweight in relation to tumour size and axillary lymph node involvement in postmenopausal breast cancer patients-differences between women invited to vs. not invited to mammography in a randomized screening trial. , 2009, Cancer epidemiology.
[10] Eero Pukkala,et al. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence , 1997, BMJ.
[11] L. Tabár,et al. Efficacy of breast cancer screening by age. New results swedish two‐county trial , 1995, Cancer.
[12] A. Miller,et al. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. , 2000, Journal of the National Cancer Institute.
[13] E. Paci,et al. Trends in Breast Cancer Mortality, Incidence, and Survival, and Mammographic screening in Tuscany, Italy , 2001, Cancer Causes & Control.
[14] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[15] S. González,et al. Mortality and recurrence patterns of breast cancer patients diagnosed under a screening programme versus comparable non-screened breast cancer patients from the same population: analytical survey from 2002 to 2012 , 2014, Tumor Biology.
[16] T. To,et al. The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years , 2002, Annals of Internal Medicine.
[17] Philippe Autier,et al. Trends in Breast Cancer Mortality in Sweden before and after Implementation of Mammography Screening , 2011, PloS one.
[18] S. Shapiro. SCREENING FOR BREAST CANCER , 1985, The Lancet.
[19] J. Otten,et al. Impressive time‐related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975‐2006 , 2008, International Journal of Cancer.
[20] L. Tabár,et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. , 2011, Radiology.
[21] E. Paci,et al. Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. , 2002, European journal of cancer.
[22] M. Hakama,et al. Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40–49 in Finland , 2011, British Journal of Cancer.
[23] Rebecca A Hubbard,et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. , 2013, JAMA internal medicine.
[24] P. Prorok,et al. An analysis of the mortality effect in a breast cancer screening study. , 1986, International journal of epidemiology.
[25] C. Mulrow,et al. Current methods of the US Preventive Services Task Force: a review of the process. , 2001, American journal of preventive medicine.
[26] L. Tabár,et al. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] Philippe Autier,et al. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Amy Cantor,et al. Screening for Breast Cancer: A Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation , 2016 .
[29] Rongwei Fu,et al. Risk Factors for Breast Cancer for Women Aged 40 to 49 Years , 2012, Annals of Internal Medicine.
[30] E. Paci,et al. Breast cancer mortality trends in two areas of the province of Florence, Italy, where screening programmes started in the 1970s and 1990s , 2004, British Journal of Cancer.
[31] D. Miglioretti,et al. Biennial versus annual mammography and the risk of late-stage breast cancer. , 2004, Journal of the National Cancer Institute.
[32] K. Boo-Chai,et al. Mammographic screening and mortality from breast cancer: The Malmo mammographic screening trial , 1990 .
[33] I. Olivotto,et al. Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50–79 in British Columbia , 2008, Journal of medical screening.
[34] S. Duffy,et al. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49. , 1997, Journal of the National Cancer Institute. Monographs.
[35] B. Møller,et al. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program , 2013, Cancer.
[36] A. Miller,et al. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[37] R. Tarone,et al. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. , 1988, Journal of the National Cancer Institute.
[38] L. Tabár,et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. , 2000, Radiologic clinics of North America.
[39] A. Wu,et al. Mammography Use Among Women Ages 40–49 After the 2009 U.S. Preventive Services Task Force Recommendation , 2013, Journal of general internal medicine.
[40] A. Miller,et al. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[41] P. Skaane,et al. Stage Distribution of Breast Cancer Diagnosed Before and After Implementation of Population-Based Mammographic Screening , 2012, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
[42] S. Moss,et al. Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years , 2005, British Journal of Cancer.
[43] S. Duffy,et al. The Gothenburg breast screening trial , 1998, Cancer.
[44] Mammographic breast cancer screening--a randomized trial in Malmö, Sweden. , 1985, Maturitas.
[45] J. Hendriks,et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review , 2003, The Lancet.
[46] Andriy I. Bandos,et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. , 2013, Radiology.
[47] D. Miglioretti,et al. Impact of Mammography Screening Interval on Breast Cancer Diagnosis by Menopausal Status and BMI , 2013, Journal of General Internal Medicine.
[48] B. Littenberg,et al. The association between the pre-diagnosis mammography screening interval and advanced breast cancer , 2007, Breast Cancer Research and Treatment.
[49] A. Verbeek,et al. Increasingly strong reduction in breast cancer mortality due to screening , 2011, British Journal of Cancer.
[50] A. Gavin,et al. Advanced breast cancer incidence following population-based mammographic screening , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[51] Tim Byers,et al. Mammography screening matters for young women with breast carcinoma , 2003, Cancer.
[52] I Andersson,et al. Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program. , 1997, Journal of the National Cancer Institute. Monographs.
[53] S G Thompson,et al. A likelihood approach to meta-analysis with random effects. , 1996, Statistics in medicine.
[54] D. Kopans,et al. Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography: A Cohort Study , 2012 .
[55] N. Day,et al. A case–control study of the impact of the East Anglian breast screening programme on breast cancer mortality , 2007, British Journal of Cancer.
[56] J. Otten,et al. Mammography Screening and Risk of Breast Cancer Death: A Population-Based Case–Control Study , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[57] S. Duffy,et al. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. , 2007, Acta radiologica.
[58] S. Duffy,et al. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales , 2004 .
[59] Gregory Doyle,et al. Pan-Canadian study of mammography screening and mortality from breast cancer. , 2014, Journal of the National Cancer Institute.
[60] S. Duffy,et al. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. , 2015, The Lancet. Oncology.
[61] H. Nelson,et al. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.
[62] P. Gøtzsche,et al. Screening for breast cancer with mammography. , 2013, The Cochrane database of systematic reviews.
[63] S Kamen,et al. The task force. , 1976, Journal of hospital dental practice.
[64] Michael Waller,et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial , 2006, The Lancet.
[65] Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction , 2008, British Journal of Cancer.
[66] S. Mook,et al. Independent prognostic value of screen detection in invasive breast cancer. , 2011, Journal of the National Cancer Institute.
[67] Håkan Jonsson,et al. Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data , 2006, Cancer Epidemiology Biomarkers & Prevention.
[68] L. Kinsinger,et al. Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence. , 2011, Preventive medicine.
[69] I. Olivotto,et al. Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia , 1999, Breast Cancer Research and Treatment.
[70] Elsebeth Lynge,et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study , 2005, BMJ : British Medical Journal.
[71] B. Møller,et al. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway. , 2014, European journal of public health.
[72] G. Eklund,et al. Randomized study of mammography screening — preliminary report on mortality in the stockholm trial , 1991, Breast Cancer Research and Treatment.
[73] Eugenio Paci,et al. Breast Cancer Mortality in Mammographic Screening in Europe: A Review of Incidence-Based Mortality Studies , 2012, Journal of medical screening.
[74] P. Gøtzsche,et al. Breast cancer mortality in organised mammography screening in Denmark: comparative study , 2010, BMJ : British Medical Journal.
[75] R. Birdwell. Weighing the Benefits and Burdens of Mammography Screening Among Women Age 80 Years or Older , 2010 .
[76] Evis Sala,et al. The Gothenburg Breast Screening Trial , 2003, Cancer.
[77] D. Miglioretti,et al. Screening for Breast Cancer With Digital Breast Tomosynthesis , 2016 .
[78] S. Shapiro,et al. Ten- to fourteen-year effect of screening on breast cancer mortality. , 1982, Journal of the National Cancer Institute.
[79] J. Habbema,et al. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. , 1986, Journal of the National Cancer Institute.
[80] L. Tabár,et al. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. , 1997, Journal of the National Cancer Institute. Monographs.
[81] M. Pollán,et al. Age-specific breast, uterine and ovarian cancer mortality trends in Spain: changes from 1980 to 2006. , 2009, Cancer epidemiology.
[82] M Broeders,et al. The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Trend Studies , 2012, Journal of medical screening.
[83] Marvin Zelen,et al. Effect of screening mammography on breast-cancer mortality in Norway. , 2010, The New England journal of medicine.
[84] M. Pons-Vigués,et al. Breast cancer mortality in Barcelona following implementation of a city breast cancer-screening program. , 2008, Cancer detection and prevention.
[85] Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England , 2010, Journal of Medical Screening.
[86] S. Heinävaara,et al. Breast cancer mortality with varying invitational policies in organised mammography , 2008, British Journal of Cancer.
[87] S. Rose,et al. Implementation of breast tomosynthesis in a routine screening practice: an observational study. , 2013, AJR. American journal of roentgenology.
[88] H. Weedon-Fekjær,et al. Effectiveness of population‐based service screening with mammography for women ages 40 to 49 years , 2012, Cancer.
[89] H. Nelson,et al. Mammography Screening in a Large Health System Following the U.S. Preventive Services Task Force Recommendations and the Affordable Care Act , 2015, PloS one.
[90] Timothy J Wilt,et al. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.
[91] H. Storm,et al. Stage and Survival in Breast Cancer Patients in Screened and Non-screened Danish and Swedish Populations , 2003, Acta oncologica.
[92] Ingvar Andersson,et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.
[93] H. Gilbert Welch,et al. Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence , 2013 .